Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

6.0K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
6.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SPECTRUM: Early clinical experience from the first global real-world study of aflibercept 8 mg in patients with diabetic macular oedema.

Eye (London, England)·2026
Same author

Correction: One-Year Outcomes of Faricimab in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report.

Ophthalmology and therapy·2026
Same author

SPECTRUM: early clinical experience from the first global real-world study of aflibercept 8 mg in patients with neovascular age-related macular degeneration.

Eye (London, England)·2026
Same author

Infographic: SPECTRUM: study design of the global real-world study of aflibercept 8 mg in the treatment of neovascular age-related macular degeneration and diabetic macular edema.

Eye (London, England)·2026
Same author

Distinguishing Inherited Retinal Disease From Age-Related Macular Degeneration: Clinical Red Flags, Diagnostic Strategy, and the Expanding Role of Genetic Testing.

Clinical & experimental ophthalmology·2026
Same author

One-Year Outcomes of Faricimab in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report.

Ophthalmology and therapy·2025

Related Experiment Video

Updated: Jul 3, 2025

Determining Gender-Based Differences in Retinal and Choroidal Thickness in Underweight Individuals via Swept-Source Optical Coherence Tomography
03:35

Determining Gender-Based Differences in Retinal and Choroidal Thickness in Underweight Individuals via Swept-Source Optical Coherence Tomography

Published on: December 1, 2023

296

Gender differences in retinal diseases: A review.

Anne Tillmann1, Lala Ceklic2,3, Chantal Dysli2,3

  • 1Augenarzt-Praxisgemeinschaft Gutblick, Pfäffikon, Switzerland.

Clinical & Experimental Ophthalmology
|February 13, 2024
PubMed
Summary
This summary is machine-generated.

Gender medicine highlights how biological and social differences impact health. This review focuses on gender disparities in retinal diseases, advocating for gender-specific ophthalmic treatments.

Keywords:
epidemiological differencesgender medicineretinal diseasessex differencesex hormones

More Related Videos

In Vitro Method to Study Sex-Based Differences in Conjunctival Goblet Cells
06:28

In Vitro Method to Study Sex-Based Differences in Conjunctival Goblet Cells

Published on: July 28, 2023

520
Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

21.6K

Related Experiment Videos

Last Updated: Jul 3, 2025

Determining Gender-Based Differences in Retinal and Choroidal Thickness in Underweight Individuals via Swept-Source Optical Coherence Tomography
03:35

Determining Gender-Based Differences in Retinal and Choroidal Thickness in Underweight Individuals via Swept-Source Optical Coherence Tomography

Published on: December 1, 2023

296
In Vitro Method to Study Sex-Based Differences in Conjunctival Goblet Cells
06:28

In Vitro Method to Study Sex-Based Differences in Conjunctival Goblet Cells

Published on: July 28, 2023

520
Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

21.6K

Area of Science:

  • Ophthalmology
  • Gender Medicine
  • Medical Research

Background:

  • Medical research historically prioritized male subjects, overlooking gender-specific health differences.
  • Gender medicine examines biological, psychological, and social factors influencing health and disease across genders.
  • Epidemiological gender differences in ophthalmological diseases are recognized, yet gender-based treatment strategies are lacking.

Purpose of the Study:

  • To review gender differences in retinal diseases.
  • To increase awareness among ophthalmologists, particularly retinologists, about gender medicine.
  • To promote personalized and gender-responsive eye care through enhanced understanding.

Main Methods:

  • Literature review focusing on gender differences in retinal diseases.
  • Analysis of existing research on epidemiological and clinical variations between genders.
  • Synthesis of information to highlight fundamental gender distinctions relevant to ophthalmology.

Main Results:

  • Significant gender disparities exist in the prevalence and progression of various retinal diseases.
  • Current ophthalmic treatment protocols often do not account for these gender-specific variations.
  • A need for gender-tailored approaches in the diagnosis and management of retinal conditions is evident.

Conclusions:

  • Integrating gender medicine principles into ophthalmology is crucial for equitable and effective patient care.
  • Developing gender-specific treatment strategies for retinal diseases will improve health outcomes.
  • Further research is needed to fully elucidate and address gender differences in eye health.